Therapy Areas: Autoimmune
Advicenne Submits European Marketing Authorization Application for ADV7103 as Treatment for Distal Renal Tubular Acidosis
13 March 2019 - - French orphan renal and neurological disease treatment developer Advicenne (PAR: ADVIC) (Euronext: ADVIC FR0013296746) has submitted a Marketing Authorization Application to the Euro...
Xencor closes on research collaboration and license agreement with Genentech
11 March 2019 - Xencor Inc (Nasdaq:XNCR), a clinical-stage biopharmaceutical company, announced on Friday the closing of its research collaboration and license agreement with Genentech, a member of th...
TaiwanJ Pharmaceuticals signs JKB-122 licensing and co-development agreement with Newsoara Biopharma for Asia
11 March 2019 - Pharmaceutical company TaiwanJ Pharmaceuticals reported on Monday the launch of a USD26m contract to license out its drug candidate JKB-122 to Newsoara Biopharma for further developmen...
Landos Biopharma Publsihes Results from Non-clinical Toxicity Studies Further Characterizing the Safety Profile of BT-11
6 March 2019 - - US-based clinical-stage biopharmaceutical company Landos Biopharma, Inc., has published findings that further characterize the safety profile of BT-11, its orally-active, gut-res...
Celltex Therapeutics Signs Memorandum of Understanding with Saudi Arabia; Expands Presence to Riyadh
6 March 2019 - - US-based biotechnology company Celltex Therapeutics Corp. has entered a memorandum of understanding with Saudi Arabia's Research Products Development Company (RPDC...
CEL-SCI's Scientific Article on Vaccines for Autoimmune Disease Published in Journal of Clinical and Cellular Immunology
5 March 2019 - - The Journal of Clinical and Cellular Immunology has published an article titled, "Why Don't We Have a Vaccine Against Autoimmune Diseases?" co-written by Dr. Ken Rosent...